The Dysregulation of the Glymphatic System in Patients with Psychosis Spectrum Disorders Minimally Exposed to Antipsychotics

被引:0
|
作者
Korann, Vittal [1 ,2 ]
Panganiban, Kristoffer J. [1 ,2 ]
Stogios, Nicolette [1 ]
Remington, Gary [1 ,2 ,3 ,4 ]
Graff-Guerrero, Ariel [2 ,3 ,4 ,5 ]
Chintoh, Araba [1 ,3 ]
Hahn, Margaret K. [1 ,2 ,3 ,6 ]
Agarwal, Sri Mahavir [1 ,2 ,3 ,6 ]
机构
[1] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, 1051 Queen St West, Toronto, ON M6J 1H3, Canada
[4] Univ Toronto Scarborough, Dept Psychol Clin Sci, Toronto, ON, Canada
[5] Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, Toronto, ON, Canada
[6] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2024年
基金
加拿大健康研究院;
关键词
psychosis; schizophrenia; DTI-ALPS; antipsychotic-minimally exposed; glymphatic system; SCHIZOPHRENIA; CLEARANCE; DISEASE; MATTER; SLEEP;
D O I
10.1177/07067437241290193
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The pathophysiological mechanisms influencing psychosis spectrum disorders are largely unknown. The glymphatic system, which is a brain waste clearance pathway, has recently been implicated in its pathophysiology and has also been shown to be disrupted in various neurodegenerative and vascular diseases. Initial studies examining the glymphatic system in psychosis spectrum disorders have reported disruptions, but the findings have been confounded by medication effects as they included antipsychotic-treated patients. In this study, we used diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) as a technique to measure the functionality of the glymphatic system in a sample of antipsychotic-minimally exposed patients with psychosis spectrum disorders and healthy controls. Methods: The study included 13 antipsychotic-minimally exposed (2 weeks antipsychotic exposure in the past 3 months/lifetime) patients with psychosis spectrum disorders and 114 healthy controls. We quantified water diffusion metrics along the x-, y-, and z-axes in both projection and association fibres to derive the DTI-ALPS index, a proxy for glymphatic activity. Between-group differences were analyzed using two-way ANCOVA controlling for age and sex. Partial correlations were used to assess the association between the ALPS index and clinical variables. Results: Analyses revealed that antipsychotic-minimally exposed psychosis spectrum disorder patients had a lower DTI-ALPS index value than healthy controls in both hemispheres and the whole brain (all P < 0.005). Significant differences were also observed between the x and y projections/associations between patients and healthy controls (P < 0.001). Furthermore, we did not find any significant correlations (all P > 0.05) between the DTI-ALPS index with age, body mass index, symptomatology, and metabolic parameters. Conclusion: This study shows that the glymphatic system is dysregulated in antipsychotic-minimally exposed patients with psychosis spectrum disorders. Understanding the mechanisms that influence the glymphatic system may help to understand the pathophysiology of psychosis spectrum disorders as proper waste clearance is needed for normal brain functioning.
引用
收藏
页数:11
相关论文
共 32 条
  • [11] Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis
    Funayama, Michitaka
    Koreki, Akihiro
    Takata, Taketo
    Kurose, Shin
    Hisamatsu, Tetsuya
    Ono, Atsushi
    Yagihashi, Tatsuhiko
    Mizushima, Jin
    Yagi, Yoshikazu
    Ogino, Satoyuki
    Oi, Hiroki
    Mimura, Yu
    Shimizu, Yusuke
    Kudo, Shun
    Nishi, Akira
    Mukai, Hiroo
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 151 : 419 - 426
  • [12] Relationship between Plasma Homovanillic Acid and Outcome in Patients with Psychosis Spectrum Disorders
    van de Kerkhof, Nora W. A.
    Fekkes, Durk
    van der Heijden, Frank M. M. A.
    Egger, Jos I. M.
    Verhoeven, Willem M. A.
    NEUROPSYCHOBIOLOGY, 2015, 71 (04) : 212 - 217
  • [13] Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study
    Balcioglu, Yasin Hasan
    Ozdemir, Sinem
    Oncu, Fatih
    Turkcan, Ahmet
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, 39 (04) : 267 - 275
  • [14] Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study
    Misiak, Blazej
    Piotrowski, Patryk
    Beszlej, Jan Aleksander
    Kalinowska, Sylwia
    Chec, Magdalena
    Samochowiec, Jerzy
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 10
  • [15] Effect of immersive virtual reality-based cognitive remediation in patients with mood or psychosis spectrum disorders: study protocol for a randomized, controlled, double-blinded trial
    Andreas E. Jespersen
    Anders Lumbye
    Maj Vinberg
    Louise Glenthøj
    Merete Nordentoft
    Eva E. Wæhrens
    Gitte M. Knudsen
    Guido Makransky
    Kamilla W. Miskowiak
    Trials, 25
  • [16] Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis
    Vita, Giovanni
    Tavella, Angelantonio
    Ostuzzi, Giovanni
    Tedeschi, Federico
    De Prisco, Michele
    Segarra, Rafael
    Solmi, Marco
    Barbui, Corrado
    Correll, Christoph U.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2024, 14
  • [17] Cognition Assessment in Virtual Reality (CAVIR): Associations with neuropsychological performance and activities of daily living in patients with mood or psychosis spectrum disorders
    Jespersen, Andreas E.
    Lumbye, Anders
    Schandorff, Johanna
    Damgaard, Viktoria
    Glenthoj, Louise B.
    Nordentoft, Merete
    Mikkelsen, Christina
    Didriksen, Maria
    Ostrowski, Sisse R.
    Vinberg, Maj
    Waehrens, Eva E.
    Miskowiak, Kamilla W.
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 369 : 1053 - 1063
  • [18] Effect of immersive virtual reality-based cognitive remediation in patients with mood or psychosis spectrum disorders: study protocol for a randomized, controlled, double-blinded trial
    Jespersen, Andreas E.
    Lumbye, Anders
    Vinberg, Maj
    Glenthoj, Louise
    Nordentoft, Merete
    Waehrens, Eva E.
    Knudsen, Gitte M.
    Makransky, Guido
    Miskowiak, Kamilla W.
    TRIALS, 2024, 25 (01)
  • [19] Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review
    Eric Druyts
    Michael J. Zoratti
    Kabirraaj Toor
    Ping Wu
    Salmaan Kanji
    Kiran Rabheru
    Edward J. Mills
    Kristian Thorlund
    BMC Pediatrics, 16
  • [20] Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review
    Druyts, Eric
    Zoratti, Michael J.
    Toor, Kabirraaj
    Wu, Ping
    Kanji, Salmaan
    Rabheru, Kiran
    Mills, Edward J.
    Thorlund, Kristian
    BMC PEDIATRICS, 2016, 16